Your browser doesn't support javascript.
loading
[Efficacy and Prognostic Factors of Estracyt ® in Patients with Castration-Resistant Prostate Cancer (CRPC) : From the Data Analysis of Estracyt ® Special Drug Use Investigation].
Murachi, Kazunori; Kumagai, Tadashi; Masuda, Tatsunori; Nakanishi, Tadaharu; Tanaka, Shinichi; Tajima, Koyuki; Takebe, Yasushi; Oda, Takayuki.
Afiliação
  • Murachi K; The Department of Marketing and Development of Urology, Nippon Shinyaku Co, LTD.
  • Kumagai T; The Department of Pharmaceutical Information, Nippon Shinyaku Co, LTD.
  • Masuda T; The Department of Pharmaceutical Information, Nippon Shinyaku Co, LTD.
  • Nakanishi T; The Department of Marketing and Development of Urology, Nippon Shinyaku Co, LTD.
  • Tanaka S; The Department of Biostatistics and Data Management, Nippon Shinyaku Co, LTD.
  • Tajima K; The Department of PMS Clinical Research, Nippon Shinyaku Co, LTD.
  • Takebe Y; The Department of PMS Clinical Research, Nippon Shinyaku Co, LTD.
  • Oda T; The Department of Pharmaceutical Information, Nippon Shinyaku Co, LTD.
Hinyokika Kiyo ; 62(6): 295-306, 2016 Jun.
Article em Ja | MEDLINE | ID: mdl-27452492
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Antineoplásicos Hormonais / Antineoplásicos Alquilantes / Estramustina / Neoplasias de Próstata Resistentes à Castração Idioma: Ja Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Antineoplásicos Hormonais / Antineoplásicos Alquilantes / Estramustina / Neoplasias de Próstata Resistentes à Castração Idioma: Ja Ano de publicação: 2016 Tipo de documento: Article